ArticleCureus2025
Evaluating the Impact of Age and Sex on Survival in Localised Anterior Uveal Melanoma Undergoing Eye-Preserving Interventions Within a Surveillance, Epidemiology, and End Results (SEER) Cohort.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose The purpose of the study was to evaluate the prognostic influence of age and sex on survival in patients with iris and ciliary body melanoma who were treated with eye-preserving interventions. Methods A retrospective cohort study was conducted using the Surveillance, Epidemiology, and End Results (SEER) database. We included patients diagnosed between 2000 and 2017 with localised iris or ciliary body melanoma who underwent local excision or radiotherapy. Kaplan-Meier curves with log-rank testing were used to assess survival differences by age (<50, 50-69, ≥70 years) and sex. We performed multivariable Cox regression to adjust for covariates. Results Ninety-nine patients met the inclusion criteria, with a median follow-up of 117 months. Age distribution was <50 years (n=17), 50-69 years (n=58), and ≥70 years (n=24). Overall survival significantly differed by age (log-rank p<0.001). Patients who were 70 years or older had more than a tenfold increased mortality risk compared with those who were younger than 50 (HR 10.65, 95% CI 2.46-46.07, p=0.002). The 50-69 years group demonstrated a trend toward increased risk (HR 3.99, 95% CI 0.94-17.01, p=0.061). In contrast, sex was not associated with survival (HR 1.02, 95% CI 0.54-1.92, p=0.944; log-rank p=0.87). Conclusions Age is a strong prognostic factor in localised iris and ciliary body melanoma treated with eye-preserving strategies, whilst sex does not influence survival. These findings underscore the value of demographic risk stratification in clinical management of anterior uveal melanoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.